Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)

Jiangsu Hengrui Medicine Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	517,255	310,587	316,838	277,811	396,571	702,753
Market Cap Growth	43.26%	-1.97%	14.05%	-29.95%	-43.57%	62.99%
Enterprise Value	478,371	286,905	298,159	258,198	375,624	684,268
PE Ratio	64.18	46.06	66.85	62.91	71.32	93.51
PS Ratio	15.66	10.43	12.60	11.55	12.47	21.34
PB Ratio	8.00	6.33	7.01	6.40	9.08	19.22
P/TBV Ratio	8.27	6.58	7.27	6.59	9.35	19.62
P/FCF Ratio	73.55	53.52	46.69	-	126.49	205.64
P/OCF Ratio	54.32	39.32	37.63	194.22	76.58	172.42
EV/Sales Ratio	14.52	9.63	11.86	10.74	11.81	20.78
EV/EBITDA Ratio	52.59	37.48	55.89	63.46	71.83	85.74
EV/EBIT Ratio	58.27	41.63	64.81	74.65	81.29	91.87
EV/FCF Ratio	68.02	49.44	43.94	-	119.81	200.23
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.00	-
Debt / EBITDA Ratio	0.01	0.02	0.02	0.37	0.04	-
Debt / FCF Ratio	0.01	0.02	0.01	-	0.06	-
Asset Turnover	0.54	0.60	0.53	0.52	0.70	0.89
Inventory Turnover	1.72	1.64	1.50	1.44	1.80	1.98
Quick Ratio	12.21	8.62	10.74	7.36	7.72	6.70
Current Ratio	13.50	9.72	12.25	8.50	8.88	7.44
Return on Equity (ROE)	14.41%	14.55%	10.77%	10.31%	13.51%	22.64%
Return on Assets (ROA)	8.45%	8.62%	6.06%	4.69%	6.36%	12.59%
Return on Capital (ROIC)	9.15%	9.27%	6.45%	5.07%	7.07%	14.07%
Return on Capital Employed (ROCE)	12.60%	13.90%	10.10%	7.90%	10.50%	20.30%
Earnings Yield	1.56%	2.17%	1.50%	1.59%	1.40%	1.07%
FCF Yield	1.36%	1.87%	2.14%	-0.30%	0.79%	0.49%
Payout Ratio	34.66%	20.12%	23.77%	26.00%	23.54%	16.07%
Buyback Yield / Dilution	-0.62%	-0.15%	1.20%	-0.36%	0.18%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.